HCA Stock: Price, Earnings History and SEC Filings
HCA Healthcare, Inc. (HCA) last traded at $473.19, down 1.02% on the latest session and up 10.9% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $7.22 against an analyst estimate of $6.74, a beat of 7.1%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
HCA earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 27, 2026 | $7.22 | $6.74 | +7.12% |
| Jun 2026 | Jul 24, 2026 | $7.59 | $7.57 | +0.26% |
| Mar 2026 | Apr 24, 2026 | $7.15 | $7.17 | -0.28% |
| Dec 2025 | Jan 27, 2026 | $8.01 | $7.36 | +8.83% |
HCA beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How HCA reacts to earnings
Across its last 8 earnings releases, HCA moved 4.4% on average the next session, in either direction. It rose after 3 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-10-27 | Before open | -3.29% |
| 2026-07-24 | Before open | +1.51% |
| 2026-07-14 | Before open | -6.95% |
| 2026-04-24 | Before open | -8.77% |
| 2026-01-27 | Before open | +7.08% |
| 2025-10-24 | Before open | +1.56% |
| 2025-07-25 | Before open | -2.10% |
| 2025-04-25 | Before open | -3.95% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
HCA financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $75.6B | $6.8B | $7.7B | 9.0% | $28.33 |
| 2024 | $70.6B | $5.8B | $5.6B | 8.2% | $22.00 |
| 2023 | $65.0B | $5.2B | $4.7B | 8.1% | $18.97 |
| 2022 | $60.2B | $5.6B | $4.1B | 9.4% | $19.15 |
| 2021 | $58.8B | $7.0B | $5.4B | 11.8% | $21.16 |
| 2020 | $51.5B | $3.8B | $6.4B | 7.3% | $10.93 |
| 2019 | $51.3B | $3.5B | $3.4B | 6.8% | $10.07 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for HCA
- 10-Q · Oct 29, 2026
- 8-K · Oct 27, 2026Results of operations, Regulation FD disclosure, Other events
- 8-K · Jul 29, 2026New financial obligation, Other events
- 10-Q · Jul 28, 2026
- 8-K · Jul 24, 2026Results of operations, Regulation FD disclosure, Other events
- 8-K · Jul 14, 2026Results of operations, Regulation FD disclosure, Financial statements and exhibits
- 8-K · Jun 18, 2026Officer or director change
- 8-K · Apr 30, 2026Material agreement, New financial obligation, Other events
- 424B5 · Apr 29, 2026
- 10-Q · Apr 29, 2026
Insider filing activity
HCA insiders filed 1 Form 4 report in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
HCA news
- HCA Q3 deep dive: payer mix shifts and resiliency initiatives shape outlookOct 30, 2026 · finance.yahoo.com
- S&P 500 Plays Defense; Investors Snack On Walmart, Mondelez As Amazon Slams TechsOct 30, 2026 · finance.yahoo.com
- What ResMed (RMD) Said on Its Q1 Earnings CallOct 30, 2026 · marketbeat.com
- THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View RaisedOct 29, 2026 · finance.yahoo.com
- Softer surgery volumes, hospital woes dampened UHS’ Q3 earningsOct 29, 2026 · healthcaredive.com
- The 5 most interesting analyst questions from HCA Healthcare’s Q3 earnings callOct 29, 2026 · finance.yahoo.com
- More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty CareOct 29, 2026 · finance.yahoo.com
- HCA’s bottom line suffers as ACA coverage losses mountOct 28, 2026 · healthcaredive.com
About HCA Healthcare, Inc.
HCA Healthcare, Inc. (HCA) is a US-listed public company on NYSE. The SEC classifies its business as Services-general Medical & Surgical Hospitals NEC. Its fiscal year ends in December.